Landing Med Information

Wuhan Landing Medical High-Tech Co., Ltd. was established in 2000 by Dr. XiaoRong Sun and her team of graduate students. With the support of leaders in our city and province and as a result of thirteen years of research and development work, Landing Med has produced a cutting-edge automated DNA image analysis system and a suite of accessory devices. These technologies are licensed under independent intellectual property rights and have reinvented the field of early cancer detection and diagnosis. Our flagship product, the Automated DNA Image Cytometer, is being used by the Hubei State Family Planning Commission to conduct cervical cancer screening for tens of thousands of rural women. At Landing Med, we adhere to the business principle of "maximizing the value of first-class cancer diagnostic technology and human health services. We believe that combining innovation and integrity leads to results that benefit everyone, and this is the value upon which we've built our operations in development, production, sales, technical services, and consulting services on the early detection and diagnosis of cancer. We aim to specialize and internationalize our brand of cytopathology and to make a positive contribution to the international health care industry and to the world. In 2010, Landing Med was named one of Wuhan's most advanced entrepreneurial enterprises. Our automated DNA image analysis system won the Advancement of Wuhan Science and Technology award. Dr. XiaoRong Sun has won many national and provincial awards including the Outstanding Entrepreneur Award, and was named one of the city's Top Ten Returning Students and Entrepreneurs and Top Ten Outstanding Entrepreneurial Women. In 2010, She was also listed as one of Contemporary China's Top Ten Outstanding Figures. Our new ¥13.12 million facility in Wuhan's Medical Device Park covers an area of 3,000 m2 and houses the Sun XiaoRong Medical Laboratory. Currently we employ 136 people, 3 of which are doctorates and 10 of which are Masters graduates. In 2008, we established a medical device manufacturer's quality management system in accordance with GB/T 19001; YY/T 0287. We also expect to obtain our ISO 13485 certification in early 2013.